INTERPARFUMS INC 8-K
Research Summary
AI-generated summary
Interparfums Inc. Changes Independent Auditor, Appoints Grant Thornton
What Happened
- Interparfums, Inc. announced via Form 8-K that its Audit Committee dismissed Forvis Mazars, LLP as the company’s independent registered public accounting firm effective May 8, 2026, and appointed Grant Thornton LLP as the new independent auditor the same day.
- Forvis’s audit reports on the consolidated financial statements for the fiscal years ended December 31, 2025 and 2024 were unmodified (no adverse opinion or disclaimer) and Forvis concurred with management’s previously disclosed conclusion that the company had not maintained effective internal control over financial reporting for those years (a disclosed material weakness).
Key Details
- Dismissal and appointment effective date: May 8, 2026.
- Prior auditor: Forvis Mazars, LLP — their reports for FYs 2025 and 2024 were unqualified and not modified.
- New auditor: Grant Thornton LLP appointed by the Audit Committee on May 8, 2026.
- No disagreements with Forvis during the two most recent fiscal years or interim period before May 8, 2026; no reportable events other than the previously disclosed material weakness in internal control over financial reporting.
- The company (and anyone acting on its behalf) did not consult Grant Thornton on accounting application or audit-opinion matters for the period from the calendar year ended December 31, 2025 through the date of the 8-K.
Why It Matters
- A change in independent auditor is a governance event investors watch closely because it can affect audit continuity, disclosure confidence, and costs. Here, the change followed the Audit Committee’s decision; prior audit reports were unmodified but included acknowledgment of a disclosed material weakness in internal controls for 2024 and 2025.
- Investors should note the material weakness remains disclosed in the company’s Form 10-Ks for those years and monitor future reports for remediation progress and any audit comments from Grant Thornton.
Loading document...